Jun 27 |
Avadel Pharmaceuticals to join Russell 3000 index
|
Jun 27 |
Avadel Pharmaceuticals to Join Russell 3000® Index
|
Jun 21 |
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
|
Jun 16 |
Avadel Pharmaceuticals: Inflection Point Ahead
|
May 22 |
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
|
May 21 |
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
|
May 13 |
Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA
|
May 10 |
Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (update)
|
May 9 |
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript
|
May 8 |
Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Call Transcript
|